KaloBios Pharmaceuticals Inc. (KBIO) News Nov 17,
Post# of 250660
Posted On: 11/21/2014 4:58:53 AM
KaloBios Pharmaceuticals Inc. (KBIO) News Nov 17, 2014, 5:31 p.m.
MarketWatch News on KBIO
Facebook shares surge after earnings beat 6:18 p.m. Jan. 29, 2014 - Wallace Witkowski
KaloBios stock slides; to stop asthma study 4:54 p.m. Jan. 29, 2014 - MarketWatch.com
KaloBios shares retreat below IPO offering price 12:37 p.m. Jan. 31, 2013 - MarketWatch.com
Other News on KBIO
Akorn (AKRX) Worth Watching: Stock Adds 6.4% in Session - Tale of the Tape 8:51 a.m. Nov. 14, 2014 - Zacks.com
KaloBios (KBIO) Looks Good: Stocks Adds 11.1% in Session - Tale of the Tape 9:25 a.m. Nov. 10, 2014 - Zacks.com
10-Q: KALOBIOS PHARMACEUTICALS INC 4:36 p.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cerulean Pharma (CERU) Worth Watching: Stock Soars 30.6% - Tale of the Tape 8:25 a.m. Aug. 14, 2014 - Zacks.com
KaloBios (KBIO) Enters Oversold Territory - Tale of the Tape 9:04 a.m. Aug. 13, 2014 - Zacks.com
Relypsa (RLYP) Worth Watching: Stock Gains 13.3% - Tale of the Tape 8:46 a.m. Aug. 11, 2014 - Zacks.com
Sanofi cuts the cord on collaboration deal with KaloBios 4:02 p.m. July 28, 2014 - Seeking Alpha
Cutera, Inc. (CUTR) in Focus: Stock Adds 7.1% in Session - Tale of the Tape 8:11 a.m. June 30, 2014 - Zacks.com
Akorn (AKRX) in Focus: Stock Moves 5.9% Higher - Tale of the Tape 8:18 a.m. June 23, 2014 - Zacks.com
Aquinox Pharmaceuticals (AQXP) in Focus: Stock Plunges 15.1% - Tale of the Tape 8:00 a.m. June 23, 2014 - Zacks.com
Acasti Pharma Inc (ACST) Jumps: Stock Rises 7.2% in Session - Tale of the Tape 7:30 a.m. June 23, 2014 - Zacks.com
Will KaloBios (KBIO) Continue to Surge Higher? - Tale of the Tape 9:22 a.m. June 13, 2014 - Zacks.com
KaloBios (KBIO) Worth Watching: Stock Jumps 12.7% - Tale of the Tape 8:25 a.m. June 11, 2014 - Zacks.com
Weakness Seen in Relypsa (RLYP): Stock Falls 7.4% - Tale of the Tape 7:58 a.m. June 11, 2014 - Zacks.com
Teva to Buy Labrys Biologics - Analyst Blog 11:10 a.m. June 4, 2014 - Zacks.com
KaloBios Pharmaceuticals (KBIO) Worth Watching: Stock Up 5.3% - Tale of the Tape 8:25 a.m. May 29, 2014 - Zacks.com
KaloBios (KBIO) is now in Oversold Territory - Tale of the Tape 6:58 a.m. May 12, 2014 - Zacks.com
10-Q: KALOBIOS PHARMACEUTICALS INC 3:09 p.m. May 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
KaloBios (KBIO) is now in Oversold Territory - Tale of the Tape 8:28 a.m. April 3, 2014 - Zacks.com
How KaloBios (KBIO) Stock Stands Out in a Strong Industry - Tale of the Tape 7:33 a.m. March 21, 2014 - Zacks.com
Press Releases on KBIO
KaloBios Announces Upcoming Scientific and Investor Conference Participation 4:05 p.m. Nov. 11, 2014 - PR Newswire - PRF
KaloBios Reports Third Quarter Financial Results 4:05 p.m. Nov. 6, 2014 - PR Newswire - PRF
Publication by KaloBios and Collaborators Shows EphA3 as Target for Highly Selective Anticancer Therapy 7:00 a.m. Aug. 14, 2014 - PR Newswire - PRF
KaloBios Provides Clinical Update and Reports Second Quarter Financial Results 7:00 a.m. Aug. 7, 2014 - PR Newswire - PRF
KaloBios Provides Update on KB001-A Partnership and Clinical Status 3:01 p.m. July 28, 2014 - PR Newswire - PRF
KaloBios to Present at 9th Annual JMP Securities Healthcare Conference 1:00 p.m. June 11, 2014 - PR Newswire - PRF
KaloBios to Present at Jefferies 2014 Global Healthcare and BBC Boston CEO Conferences 11:28 a.m. May 21, 2014 - PR Newswire - PRF
KaloBios Provides First Quarter 2014 Financial Results 3:01 p.m. May 8, 2014 - PR Newswire - PRF
Ted W. Love, M.D., Named Chairman of the Board of KaloBios 3:01 p.m. May 6, 2014 - PR Newswire - PRF
KaloBios Announces Upcoming Participation at Needham Healthcare Conference 6:30 p.m. April 3, 2014 - PR Newswire - PRF
KaloBios Announces Fiscal Year 2013 Financial Results 3:01 p.m. March 13, 2014 - PR Newswire - PRF
KaloBios Announces Upcoming Participation at ROTH and BioCentury's Future Leaders in the Biotech Industry Conferences 3:01 p.m. March 10, 2014 - PR Newswire - PRF
KaloBios Initiates Phase 2 Expansion Portion of Study of KB004 in Hematologic Malignancies 8:00 a.m. Feb. 11, 2014 - PR Newswire - PRF
KaloBios Announces Upcoming Webcasts and Conference Participation 6:00 p.m. Feb. 5, 2014 - PR Newswire - PRF
KaloBios Reports Top-Line Data for Phase 2 Study of KB003 in Severe Asthma 4:01 p.m. Jan. 29, 2014 - PR Newswire - PRF
KaloBios Appoints Harry Lam, Ph.D. as Head of Manufacturing 8:00 a.m. Jan. 7, 2014 - PR Newswire
KaloBios Announces Preliminary Phase 1 Results in Advanced Hematologic Malignancies with KB004, an Anti-EphA3 Monoclonal Antibody 9:00 a.m. Dec. 10, 2013 - PR Newswire
KaloBios Receives Notice of Allowance for Key Composition of Matter Patent Covering KBOO4 5:07 p.m. Dec. 5, 2013 - PR Newswire
KaloBios Reports Third Quarter 2013 Financial Results 8:00 a.m. Nov. 12, 2013 - PR Newswire
KaloBios to Present KB004 Interim Phase 1 Clinical Data in Hematologic Malignancies at ASH 8:00 a.m. Nov. 7, 2013 - PR Newswire
MarketWatch News on KBIO
Facebook shares surge after earnings beat 6:18 p.m. Jan. 29, 2014 - Wallace Witkowski
KaloBios stock slides; to stop asthma study 4:54 p.m. Jan. 29, 2014 - MarketWatch.com
KaloBios shares retreat below IPO offering price 12:37 p.m. Jan. 31, 2013 - MarketWatch.com
Other News on KBIO
Akorn (AKRX) Worth Watching: Stock Adds 6.4% in Session - Tale of the Tape 8:51 a.m. Nov. 14, 2014 - Zacks.com
KaloBios (KBIO) Looks Good: Stocks Adds 11.1% in Session - Tale of the Tape 9:25 a.m. Nov. 10, 2014 - Zacks.com
10-Q: KALOBIOS PHARMACEUTICALS INC 4:36 p.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cerulean Pharma (CERU) Worth Watching: Stock Soars 30.6% - Tale of the Tape 8:25 a.m. Aug. 14, 2014 - Zacks.com
KaloBios (KBIO) Enters Oversold Territory - Tale of the Tape 9:04 a.m. Aug. 13, 2014 - Zacks.com
Relypsa (RLYP) Worth Watching: Stock Gains 13.3% - Tale of the Tape 8:46 a.m. Aug. 11, 2014 - Zacks.com
Sanofi cuts the cord on collaboration deal with KaloBios 4:02 p.m. July 28, 2014 - Seeking Alpha
Cutera, Inc. (CUTR) in Focus: Stock Adds 7.1% in Session - Tale of the Tape 8:11 a.m. June 30, 2014 - Zacks.com
Akorn (AKRX) in Focus: Stock Moves 5.9% Higher - Tale of the Tape 8:18 a.m. June 23, 2014 - Zacks.com
Aquinox Pharmaceuticals (AQXP) in Focus: Stock Plunges 15.1% - Tale of the Tape 8:00 a.m. June 23, 2014 - Zacks.com
Acasti Pharma Inc (ACST) Jumps: Stock Rises 7.2% in Session - Tale of the Tape 7:30 a.m. June 23, 2014 - Zacks.com
Will KaloBios (KBIO) Continue to Surge Higher? - Tale of the Tape 9:22 a.m. June 13, 2014 - Zacks.com
KaloBios (KBIO) Worth Watching: Stock Jumps 12.7% - Tale of the Tape 8:25 a.m. June 11, 2014 - Zacks.com
Weakness Seen in Relypsa (RLYP): Stock Falls 7.4% - Tale of the Tape 7:58 a.m. June 11, 2014 - Zacks.com
Teva to Buy Labrys Biologics - Analyst Blog 11:10 a.m. June 4, 2014 - Zacks.com
KaloBios Pharmaceuticals (KBIO) Worth Watching: Stock Up 5.3% - Tale of the Tape 8:25 a.m. May 29, 2014 - Zacks.com
KaloBios (KBIO) is now in Oversold Territory - Tale of the Tape 6:58 a.m. May 12, 2014 - Zacks.com
10-Q: KALOBIOS PHARMACEUTICALS INC 3:09 p.m. May 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
KaloBios (KBIO) is now in Oversold Territory - Tale of the Tape 8:28 a.m. April 3, 2014 - Zacks.com
How KaloBios (KBIO) Stock Stands Out in a Strong Industry - Tale of the Tape 7:33 a.m. March 21, 2014 - Zacks.com
Press Releases on KBIO
KaloBios Announces Upcoming Scientific and Investor Conference Participation 4:05 p.m. Nov. 11, 2014 - PR Newswire - PRF
KaloBios Reports Third Quarter Financial Results 4:05 p.m. Nov. 6, 2014 - PR Newswire - PRF
Publication by KaloBios and Collaborators Shows EphA3 as Target for Highly Selective Anticancer Therapy 7:00 a.m. Aug. 14, 2014 - PR Newswire - PRF
KaloBios Provides Clinical Update and Reports Second Quarter Financial Results 7:00 a.m. Aug. 7, 2014 - PR Newswire - PRF
KaloBios Provides Update on KB001-A Partnership and Clinical Status 3:01 p.m. July 28, 2014 - PR Newswire - PRF
KaloBios to Present at 9th Annual JMP Securities Healthcare Conference 1:00 p.m. June 11, 2014 - PR Newswire - PRF
KaloBios to Present at Jefferies 2014 Global Healthcare and BBC Boston CEO Conferences 11:28 a.m. May 21, 2014 - PR Newswire - PRF
KaloBios Provides First Quarter 2014 Financial Results 3:01 p.m. May 8, 2014 - PR Newswire - PRF
Ted W. Love, M.D., Named Chairman of the Board of KaloBios 3:01 p.m. May 6, 2014 - PR Newswire - PRF
KaloBios Announces Upcoming Participation at Needham Healthcare Conference 6:30 p.m. April 3, 2014 - PR Newswire - PRF
KaloBios Announces Fiscal Year 2013 Financial Results 3:01 p.m. March 13, 2014 - PR Newswire - PRF
KaloBios Announces Upcoming Participation at ROTH and BioCentury's Future Leaders in the Biotech Industry Conferences 3:01 p.m. March 10, 2014 - PR Newswire - PRF
KaloBios Initiates Phase 2 Expansion Portion of Study of KB004 in Hematologic Malignancies 8:00 a.m. Feb. 11, 2014 - PR Newswire - PRF
KaloBios Announces Upcoming Webcasts and Conference Participation 6:00 p.m. Feb. 5, 2014 - PR Newswire - PRF
KaloBios Reports Top-Line Data for Phase 2 Study of KB003 in Severe Asthma 4:01 p.m. Jan. 29, 2014 - PR Newswire - PRF
KaloBios Appoints Harry Lam, Ph.D. as Head of Manufacturing 8:00 a.m. Jan. 7, 2014 - PR Newswire
KaloBios Announces Preliminary Phase 1 Results in Advanced Hematologic Malignancies with KB004, an Anti-EphA3 Monoclonal Antibody 9:00 a.m. Dec. 10, 2013 - PR Newswire
KaloBios Receives Notice of Allowance for Key Composition of Matter Patent Covering KBOO4 5:07 p.m. Dec. 5, 2013 - PR Newswire
KaloBios Reports Third Quarter 2013 Financial Results 8:00 a.m. Nov. 12, 2013 - PR Newswire
KaloBios to Present KB004 Interim Phase 1 Clinical Data in Hematologic Malignancies at ASH 8:00 a.m. Nov. 7, 2013 - PR Newswire
(0)
(0)